Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

embed
 plays        
How to Play
HintAnswer
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
P-kinetics: Start with a small dose
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
P-kinetics: Given PO. Loses effectiveness over time.
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
Use: alleviation of chorea
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
Use: Most effective drug in tx of Tourette's
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Clonazepam class
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
Ropinirole class
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
Use: prolong ALS survival by months
Riluzole class
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
Use: depression associated with Huntington's disease
Procyclidine class
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
Butyrophenones class
Use: Gold standard in Parkinson's dz - most efficacious treatment
Benzotropine class
Trihexyphenidyl class
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
HintAnswer
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
P-kinetics: Similar to Pramipexole
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
MOA: Pure D2 receptor agonist
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
Phenothiazine class
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
Risperidone class
Reserpine class
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
Clonidine class
Olanzapine class
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
SSRI class
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
Levodopa class
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
Carbidopa + levidopa (1:10 or 1:4)
Use: Similar to Pramipexole
Fluphenzaine class
Tetrabenxine class
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
MOA: D2 receptor agonist (partial D1 agonist)
Carbidopa class
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
P-kinetics: Start at low dose & gradually increase
Entacapone class
Tolcapone class
HintAnswer
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
MOA: Central (brain) anti-cholinergic
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
Pramipexole class
Bromocriptine class
Selegiline class
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
MOA: D1 and D2 receptor agonist
Carbamazepine class
Orphenadrine class
SE: Insomnia when taken late in the day
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
MOA: Preferential affinity for D3 family of receptors
Quetiapine class
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
Haloperidol class
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
Pergolide class
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
Apomorphine class
Use: alleviation of chorea if refractory to atypical
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
Rasagiline class
Amantadine class
TCA class
Biperiden class

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...

Show Comments

Extras